StonvexLoading…
StonvexStonvexStonvexCore line items from SHBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.85M | $20.91M | $18.34M | $15.34M |
Operating Income | $78.66M | $58.70M | $14.18M | $42.14M |
Net Income | $59.51M | $43.89M | $11.23M | $31.18M |
EPS (Diluted) | $1.78 | $1.32 | $0.42 | $1.57 |
Total Assets | $6.26B | $6.23B | $6.01B | $3.48B |
Total Liabilities | $5.67B | $5.69B | $5.50B | $3.11B |
Cash & Equivalents | $355.57M | $459.85M | $372.41M | $55.50M |
Free Cash Flow OCF − CapEx | $59.22M | $41.66M | $16.76M | $50.23M |
Shares Outstanding | 33.41M | 33.33M | 33.16M | 19.86M |